<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Zoledronic acid</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Zoledronic_acid">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Zoledronic acid</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Zoledronic acid</b>, also known as <b>zoledronate</b>, is a medication used to treat a number of bone diseases.<span class="mw-ref" id="cite_ref-AHFS2017_2-2"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, and Paget’s disease of bone.<span class="mw-ref" id="cite_ref-AHFS2017_2-3"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is given by injection into a vein.<span class="mw-ref" id="cite_ref-AHFS2017_2-4"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Zoledronic acid</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Zoledronic_acid.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Zoledronic_acid.svg.png" data-file-width="400" data-file-height="370" data-file-type="drawing" height="167" width="180"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Zoledronic-acid-from-xtal-2003-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Zoledronic-acid-from-xtal-2003-3D-balls.png" data-file-width="3500" data-file-height="3099" data-file-type="bitmap" height="159" width="180"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Reclast, Zometa, others<span class="mw-ref" id="cite_ref-drugs.comINT_1-0"><a href="#cite_note-drugs.comINT-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/zoledronic_acid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/zoledronic_acid.html'" tppabs="https://www.drugs.com/monograph/zoledronic_acid.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a605023.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a605023.html'" tppabs="https://medlineplus.gov/druginfo/meds/a605023.html" class="external text external">a605023</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Zoledronic+acid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Zoledronic+acid'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Zoledronic+acid" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Zoledronic_acid&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Zoledronic_acid&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Zoledronic_acid&SearchType=BasicSearch" class="external text external">Zoledronic_acid</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>D <small>(U.S.)</small><span class="mw-ref" id="cite_ref-AHFS2017_2-0"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Intravenous</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Bisphosphonate<span class="mw-ref" id="cite_ref-AHFS2017_2-1"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>M05BA08<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=M05BA08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=M05BA08'" tppabs="https://www.whocc.no/atc_ddd_index/?code=M05BA08" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>22%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Nil</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>146 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney (partial)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">[1-hydroxy-2-(1<i>H</i>-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=118072-93-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=118072-93-8'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=118072-93-8" class="external text external">118072-93-8</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/68740  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/68740'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/68740" class="external text external">68740</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3177'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3177" class="external text external">3177</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00399'" tppabs="https://www.drugbank.ca/drugs/DB00399" class="external text external">DB00399</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.61986.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.61986.html'" tppabs="http://www.chemspider.com/Chemical-Structure.61986.html" class="external text external">61986</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=70HZ18PH24  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=70HZ18PH24'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=70HZ18PH24" class="external text external">70HZ18PH24</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D08689  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D08689'" tppabs="https://www.kegg.jp/entry/D08689" class="external text external">D08689</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL924  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL924'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL924" class="external text external">ChEMBL924</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>ZOL (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ZOL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ZOL'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ZOL" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=ZOL&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=ZOL&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=ZOL&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0042668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0042668'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0042668" class="external text external">DTXSID0042668</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>5</sub><span>H</span><sub>10</sub><span>N</span><sub>2</sub><span>O</span><sub>7</sub><span>P</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">272.090</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP%28O%29%28O%29C%28O%29%28Cn1ccnc1%29P%28%3DO%29%28O%29O  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP%28O%29%28O%29C%28O%29%28Cn1ccnc1%29P%28%3DO%29%28O%29O'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP%28O%29%28O%29C%28O%29%28Cn1ccnc1%29P%28%3DO%29%28O%29O" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)</div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:XRASPMIURGNCCH-UHFFFAOYSA-N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=396274597&page2=Zoledronic+acid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=396274597&page2=Zoledronic+acid'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=396274597&page2=Zoledronic+acid" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include fever, joint pain, high blood pressure, diarrhea, and feeling tired.<span class="mw-ref" id="cite_ref-AHFS2017_2-5"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Serious side effects may include kidney problems, low blood calcium, and osteonecrosis of the jaw.<span class="mw-ref" id="cite_ref-AHFS2017_2-6"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Use during pregnancy may result in harm to the baby.<span class="mw-ref" id="cite_ref-AHFS2017_2-7"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is in the bisphosphonate family of medications.<span class="mw-ref" id="cite_ref-AHFS2017_2-8"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It works by blocking the activity of osteoclast cells and thus decreases the breakdown of bone.<span class="mw-ref" id="cite_ref-AHFS2017_2-9"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


<p>Zoledronic acid was patented in 1986 and approved for medical use in the United States in 2001.<span class="mw-ref" id="cite_ref-AHFS2017_2-10"><a href="#cite_note-AHFS2017-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Fis2006_3-0"><a href="#cite_note-Fis2006-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_4-0"><a href="#cite_note-WHO21st-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Bone_complications_of_cancer">Bone complications of cancer</h3></summary>
    

<p>Zoledronic acid is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases.<span class="mw-ref" id="cite_ref-zomera_6-0"><a href="#cite_note-zomera-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>It can be given at home rather than in hospital. Such use has shown safety and quality-of-life benefits in people with breast cancer and bone metastases.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Osteoporosis">Osteoporosis</h3></summary>
    
<p>Zoledronic acid may be given as a 5<span>&nbsp;</span>mg infusion once per year for treatment of osteoporosis in men and post-menopausal women at increased risk of fracture.<span class="mw-ref" id="cite_ref-Lyles_8-0"><a href="#cite_note-Lyles-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>In 2007, the U.S. Food and Drug Administration (FDA) also approved it for the treatment of postmenopausal osteoporosis.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-black_10-0"><a href="#cite_note-black-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other">Other</h3></summary>
    

<p>Zoledronate may be used for treatment of osteogenesis imperfecta.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>A single 5<span>&nbsp;</span>mg dose of zoledronic acid is used for the treatment of Paget's disease.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<ul><li>Poor renal function (e.g. CrCl&lt;30 mL/min)<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Hypocalcaemia</li>
<li>Pregnancy</li>
<li>Paralysis</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Side effects can include fatigue, anemia, muscle aches, fever, and/or swelling in the feet or legs. Flu-like symptoms are common after the first infusion, although not subsequent infusions, and are thought to occur because of its potential to activate human γδ T cells (gamma/delta T cells).</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Kidneys">Kidneys</h3></summary>
    
<p>There is a risk of severe renal impairment. Appropriate hydration is important prior to administration, as is adequate <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a> and <a href="Vitamin_D.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_D" title="Vitamin D">vitamin D</a> intake prior to Aclasta therapy in patients with preexisting hypocalcaemia, and for ten days following Aclasta in patients with Paget's disease of the bone. Monitoring for other mineral metabolism disorders and the avoidance of invasive dental procedures for those who develop osteonecrosis of the jaw is recommended.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Zoledronate is rapidly processed via the kidneys; consequently its administration is not recommended for patients with reduced renal function or kidney disease.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Some cases of acute kidney injury either requiring dialysis or having a fatal outcome following Reclast use have been reported to the U.S. Food and Drug Administration (FDA).<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> This assessment was confirmed by the European Medicines Agency (EMA), whose Committee for Medicinal Products for Human Use (CHMP) specified new contraindications for the medication on 15 December 2011, which include hypocalcaemia and severe renal impairment with a <a href="Creatinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Creatinine" title="Creatinine">creatinine</a> clearance of less than 35 ml/min.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Bone">Bone</h3></summary>
    
<p>A rare complication that has been recently observed in cancer patients being treated with bisphosphonates is osteonecrosis of the jaw.  This has mainly been seen in patients with multiple myeloma treated with zoledronate who have had dental extractions.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Atypical fractures<span>&nbsp;</span>: After approving the drug on 8 July 2009, the European Medicines Agency conducted a class review of all bisphosphonates, including Zoledronate, after several cases of atypical fractures were reported.<span class="mw-ref" id="cite_ref-ema.europa.eu_19-0"><a href="#cite_note-ema.europa.eu-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> In 2008, the EMA's Pharmacovigilance Working Party (PhVWP) noted that <a href="Alendronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Alendronic_acid" title="Alendronic acid">alendronic acid</a> was associated with an increased risk of atypical fracture of the femur that developed with low or no trauma. In April 2010, the PhVWP noted that further data from both the published literature and post-marketing reports were now available which suggested that atypical stress fractures of the femur may be a class effect. The European Medicines Agency then reviewed all case reports of stress fractures in patients treated with bisphosphonates, relevant data from the published literature, and data provided by the companies which market bisphosphonates. The Agency recommended that doctors who prescribe bisphosphonate-containing medicines should be aware that atypical fractures may occur rarely in the femur, especially after long-term use, and that doctors who are prescribing these medicines for the prevention or treatment of osteoporosis should regularly review the need for continued treatment, especially after five or more years of use.<span class="mw-ref" id="cite_ref-ema.europa.eu_19-1"><a href="#cite_note-ema.europa.eu-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>Zoledronic acid slows down bone resorption, allowing the bone-forming cells time to rebuild normal bone and allowing bone remodeling.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<table class="wikitable">
<caption>Relative potency<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></caption>
<tbody><tr><th>Bisphosphonate</th>
<th>Relative potency</th></tr>
<tr>
<td><a href="Etidronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Etidronic_acid" title="Etidronic acid">Etidronate</a></td>
<td>1</td></tr>
<tr>
<td><a href="Tiludronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiludronic_acid" title="Tiludronic acid">Tiludronate</a></td>
<td>10</td></tr>
<tr>
<td><a href="Pamidronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Pamidronic_acid" title="Pamidronic acid">Pamidronate</a></td>
<td>100</td></tr>
<tr>
<td><a href="Alendronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Alendronic_acid" title="Alendronic acid">Alendronate</a></td>
<td>100-500</td></tr>
<tr>
<td><a href="Ibandronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibandronic_acid" title="Ibandronic acid">Ibandronate</a></td>
<td>500-1000</td></tr>
<tr>
<td><a href="Risedronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Risedronic_acid" title="Risedronic acid">Risedronate</a></td>
<td>1000</td></tr>
<tr>
<td>Zoledronate</td>
<td>5000</td></tr>
</tbody></table>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Zoledronic acid has been found to have a direct antitumor effect and to synergistically augment the effects of other antitumor agents in osteosarcoma cells.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>Zoledronate has shown significant benefits versus placebo over three years, with a reduced number of vertebral fractures and improved markers of bone density.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-black_10-1"><a href="#cite_note-black-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span>  An annual dose of zoledronic acid may also prevent recurring fractures in patients with a previous hip fracture.<span class="mw-ref" id="cite_ref-Lyles_8-1"><a href="#cite_note-Lyles-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Zoledronate also attenuates accumulation of DNA damage in mesenchymal stem cells and protects their function.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> Given this characteristic, its potential to affect conditions arising from stem-cell dysfunction makes it a promising medicine for a range of age-related diseases<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="With_hormone_therapy_for_breast_cancer">With hormone therapy for breast cancer</h3></summary>
    
<p>An increase in disease-free survival (DFS) was found in the ABCSG-12 trial, in which 1,803 premenopausal women with endocrine-responsive early breast cancer received <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">anastrozole</a> with zoledronic acid.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span>  A retrospective analysis of the AZURE trial data revealed a DFS survival advantage, particularly where estrogen had been reduced.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>
  
<p>In a meta-analysis of trials where upfront zoledronic acid was given to prevent aromatase inhibitor-associated bone loss, active cancer recurrence appeared to be reduced.<span class="mw-ref" id="cite_ref-pmid18515735_28-0"><a href="#cite_note-pmid18515735-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>
  
<p><span>As of 2010</span> "The results of clinical studies of adjuvant treatment on early-stage hormone-receptor-positive breast-cancer patients under hormonal treatment – especially with the bisphosphonate zoledronic acid – caused excitement because they demonstrated an additive effect on decreasing disease relapses at bone or other sites. A number of clinical and <i>in vitro</i> and <i>in vivo</i> preclinical studies, which are either ongoing or have just ended, are investigating the mechanism of action  and antitumoral activity of bisphosphonates."<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>A 2010 review concluded that "adding zoledronic acid 4 mg intravenously every 6 months to endocrine therapy in premenopausal women with hormone receptor-positive early breast cancer ... is cost-effective from a US health care system perspective".<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-drugs.comINT-1"> <span id="mw-reference-text-cite_note-drugs.comINT-1" class="mw-reference-text">Drugs.com <a href="javascript:if(confirm('https://www.drugs.com/international/zoledronic-acid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/zoledronic-acid.html'" tppabs="https://www.drugs.com/international/zoledronic-acid.html" class="external text external">International trade names for zoledronic acid</a> Page accessed Jan 14, 2015</span></li><li id="cite_note-AHFS2017-2"> <span id="mw-reference-text-cite_note-AHFS2017-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/zoledronic-acid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/zoledronic-acid.html'" tppabs="https://www.drugs.com/monograph/zoledronic-acid.html" class="external text external">"Zoledronic Acid"</a>. The American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2017</span>.</cite></span></li><li id="cite_note-Fis2006-3"> <span id="mw-reference-text-cite_note-Fis2006-3" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA524'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA524" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>524. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-WHO21st-4"> <span id="mw-reference-text-cite_note-WHO21st-4" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text">National Prescribing Service (2009). "Zoledronic Acid for Osteoporosis". <i>Medicines Update</i>, Available at <cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100423105839/http://www.nps.org.au/consumers/publications/medicine_update/issues/zoledronic_acid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100423105839/http://www.nps.org.au/consumers/publications/medicine_update/issues/zoledronic_acid'" tppabs="https://web.archive.org/web/20100423105839/http://www.nps.org.au/consumers/publications/medicine_update/issues/zoledronic_acid" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('http://www.nps.org.au/consumers/publications/medicine_update/issues/Zoledronic_acid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nps.org.au/consumers/publications/medicine_update/issues/Zoledronic_acid'" tppabs="http://www.nps.org.au/consumers/publications/medicine_update/issues/Zoledronic_acid" class="external text external">the original</a> on April 23, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">January 20,</span> 2010</span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-zomera-6"> <span id="mw-reference-text-cite_note-zomera-6" class="mw-reference-text"><a href="javascript:if(confirm('http://www.health.gov.il/units/pharmacy/trufot/alonim/533.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.health.gov.il/units/pharmacy/trufot/alonim/533.pdf'" tppabs="http://www.health.gov.il/units/pharmacy/trufot/alonim/533.pdf" class="external free external">http://www.health.gov.il/units/pharmacy/trufot/alonim/533.pdf</a> Zomera prescribing information</span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFWardleyDavidsonBarrett-Lee2005" class="citation journal cs1">Wardley, A; Davidson, N; Barrett-Lee, P;  et al. (May 2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361764'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361764" class="external text external">"Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration"</a>. <i>Br. J. Cancer</i>. <b>92</b> (10): 1869–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bjc.6602551  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bjc.6602551'" tppabs="https://doi.org/10.1038%2Fsj.bjc.6602551" class="external text external">10.1038/sj.bjc.6602551</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361764'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361764" class="external text external">2361764</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15870721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15870721'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15870721" class="external text external">15870721</a>.</cite></span></li><li id="cite_note-Lyles-8"> <span id="mw-reference-text-cite_note-Lyles-8" class="mw-reference-text"><cite id="CITEREFLyles2007" class="citation journal cs1">Lyles K,  et al. (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324066'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324066" class="external text external">"Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture"</a>. <i>N. Engl. J. Med</i>. <b>357</b> (18): 1799–809. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa074941  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa074941'" tppabs="https://doi.org/10.1056%2FNEJMoa074941" class="external text external">10.1056/NEJMoa074941</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324066'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324066" class="external text external">2324066</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17878149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17878149'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17878149" class="external text external">17878149</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><a href="javascript:if(confirm('https://www.fiercebiotech.com/biotech/press-release-novartis-s-reclast-receives-fda-approval-for-women-postmenopausal  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fiercebiotech.com/biotech/press-release-novartis-s-reclast-receives-fda-approval-for-women-postmenopausal'" tppabs="https://www.fiercebiotech.com/biotech/press-release-novartis-s-reclast-receives-fda-approval-for-women-postmenopausal" class="external text external">"Biotech PRESS RELEASE: Novartis's Reclast Receives FDA Approval FOR Women With Postmenopausal Osteoporosis"</a>, FierceBiotech, A Division of Questex A FierceMarkets Publication Aug 20, 2007.  Retrieved 2018-03-27</span></li><li id="cite_note-black-10"> <span id="mw-reference-text-cite_note-black-10" class="mw-reference-text"><cite id="CITEREFBlack2007" class="citation journal cs1">Black;  et al. (2007). "Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis". <i>NEJM</i>. <b>356</b> (18): 1809–1822. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2Fnejmoa067312  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2Fnejmoa067312'" tppabs="https://doi.org/10.1056%2Fnejmoa067312" class="external text external">10.1056/nejmoa067312</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17476007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17476007'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17476007" class="external text external">17476007</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:71443125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:71443125'" tppabs="https://api.semanticscholar.org/CorpusID:71443125" class="external text external">71443125</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFDwanPhillipiSteinerBasel2016" class="citation journal cs1">Dwan, K; Phillipi, CA; Steiner, RD; Basel, D (19 October 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611487'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611487" class="external text external">"Bisphosphonate therapy for osteogenesis imperfecta"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>10</b>: CD005088. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD005088.pub4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD005088.pub4'" tppabs="https://doi.org/10.1002%2F14651858.CD005088.pub4" class="external text external">10.1002/14651858.CD005088.pub4</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611487'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611487" class="external text external">6611487</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27760454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27760454'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27760454" class="external text external">27760454</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Paget_s_Disease_of_Bone/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Paget_s_Disease_of_Bone/'" tppabs="http://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Paget_s_Disease_of_Bone/" class="external text external">"Paget's Disease of Bone"</a>. <i>www.rheumatology.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-09</span></span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFVondracek2010" class="citation journal cs1">Vondracek, S. F. (2010). "Managing osteoporosis in postmenopausal women". <i>American Journal of Health-System Pharmacy</i>. <b>67</b> (7 Suppl 3): S9–19. doi:<a href="javascript:if(confirm('https://doi.org/10.2146%2Fajhp100076  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2146%2Fajhp100076'" tppabs="https://doi.org/10.2146%2Fajhp100076" class="external text external">10.2146/ajhp100076</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20332498  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20332498'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20332498" class="external text external">20332498</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160304042644/http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160304042644/http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf'" tppabs="https://web.archive.org/web/20160304042644/http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf" class="external text external">"NPS MedicineWise"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf'" tppabs="http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2016-03-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-01-25</span></span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100224070712/http://www.emc.medicines.org.uk/medicine/14062/SPC/Zometa%204mg%205ml%20Concentrate%20for%20Solution%20for%20Infusion  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100224070712/http://www.emc.medicines.org.uk/medicine/14062/SPC/Zometa%204mg%205ml%20Concentrate%20for%20Solution%20for%20Infusion'" tppabs="https://web.archive.org/web/20100224070712/http://www.emc.medicines.org.uk/medicine/14062/SPC/Zometa%204mg%205ml%20Concentrate%20for%20Solution%20for%20Infusion" class="external text external">"Zometa 4mg/5ml Concentrate for Solution for Infusion"</a>. <i>medicines.org.uk</i>. Archived from <a href="javascript:if(confirm('http://emc.medicines.org.uk/medicine/14062/SPC/Zometa+4mg+5ml+Concentrate+for+Solution+for+Infusion/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emc.medicines.org.uk/medicine/14062/SPC/Zometa+4mg+5ml+Concentrate+for+Solution+for+Infusion/'" tppabs="http://emc.medicines.org.uk/medicine/14062/SPC/Zometa+4mg+5ml+Concentrate+for+Solution+for+Infusion/" class="external text external">the original</a> on 2010-02-24<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-02-24</span></span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/fda/reclast-zoledronic-acid-safety-communication-new-updated-warning-kidney-impairment-13020.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/fda/reclast-zoledronic-acid-safety-communication-new-updated-warning-kidney-impairment-13020.html'" tppabs="https://www.drugs.com/fda/reclast-zoledronic-acid-safety-communication-new-updated-warning-kidney-impairment-13020.html" class="external text external">"FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment"</a>. <i>drugs.com</i>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000595/smops/Positive/human_smop_000319.jsp&mid=WC0b01ac058001d127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000595/smops/Positive/human_smop_000319.jsp&mid=WC0b01ac058001d127'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000595/smops/Positive/human_smop_000319.jsp&mid=WC0b01ac058001d127" class="external text external">"European Medicines Agency - Human medicines"</a>. <i>europa.eu</i>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFDurieKatzCrowley2005" class="citation journal cs1">Durie BG, Katz M, Crowley J (2005). "Osteonecrosis of the jaw and bisphosphonates". <i>N. Engl. J. Med</i>. <b>353</b> (1): 99–102, discussion 99–102. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM200507073530120  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM200507073530120'" tppabs="https://doi.org/10.1056%2FNEJM200507073530120" class="external text external">10.1056/NEJM200507073530120</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16000365  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16000365'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16000365" class="external text external">16000365</a>.</cite></span></li><li id="cite_note-ema.europa.eu-19"> <span id="mw-reference-text-cite_note-ema.europa.eu-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/04/human_pha_detail_000027.jsp&mid=WC0b01ac058001d126  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/04/human_pha_detail_000027.jsp&mid=WC0b01ac058001d126'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/04/human_pha_detail_000027.jsp&mid=WC0b01ac058001d126" class="external text external">"European Medicines Agency - Human medicines"</a>. <i>europa.eu</i>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160304042644/http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160304042644/http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf'" tppabs="https://web.archive.org/web/20160304042644/http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf" class="external text external">"Aclasta label- Australia"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf'" tppabs="http://www.nps.org.au/__data/assets/pdf_file/0006/60945/nvcaclin.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2016-03-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-01-25</span></span>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFD.2013" class="citation book cs1">D., Tripathi, K. (2013-09-30). <i>Essentials of medical pharmacology</i> (Seventh ed.). New Delhi. ISBN<span>&nbsp;</span><bdi>9789350259375</bdi>. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/868299888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/868299888'" tppabs="https://www.worldcat.org/oclc/868299888" class="external text external">868299888</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFKotoMurataKimura2010" class="citation journal cs1">Koto K, Murata H, Kimura S,  et al. (July 2010). <a href="javascript:if(confirm('https://doi.org/10.3892/or_00000851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3892/or_00000851'" tppabs="https://doi.org/10.3892/or_00000851" class="external text external">"Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents"</a>. <i>Oncol. Rep</i>. <b>24</b> (1): 233–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.3892%2For_00000851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3892%2For_00000851'" tppabs="https://doi.org/10.3892%2For_00000851" class="external text external">10.3892/or_00000851</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20514467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20514467'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20514467" class="external text external">20514467</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFReidBrownBurckhardtHorowitz2002" class="citation journal cs1">Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ (2002). "Intravenous zoledronic acid in postmenopausal women with low bone mineral density". <i>N. Engl. J. Med</i>. <b>346</b> (9): 653–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa011807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa011807'" tppabs="https://doi.org/10.1056%2FNEJMoa011807" class="external text external">10.1056/NEJMoa011807</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11870242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11870242'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11870242" class="external text external">11870242</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFMisraMohantyMadanFernandes2016" class="citation journal cs1">Misra, Juhi; Mohanty, Sindhu T.; Madan, Sanjeev; Fernandes, James A.; Hal Ebetino, F.; Russell, R. Graham G.; Bellantuono, Ilaria (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832316  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832316'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832316" class="external text external">"Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function"</a>. <i>Stem Cells</i>. <b>34</b> (3): 756–767. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fstem.2255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fstem.2255'" tppabs="https://doi.org/10.1002%2Fstem.2255" class="external text external">10.1002/stem.2255</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832316  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832316'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832316" class="external text external">4832316</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26679354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26679354'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26679354" class="external text external">26679354</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><a href="javascript:if(confirm('https://www.sciencedaily.com/releases/2015/12/151217082458.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sciencedaily.com/releases/2015/12/151217082458.htm'" tppabs="https://www.sciencedaily.com/releases/2015/12/151217082458.htm" class="external text external">"Bone drug protects stem cells from aging."</a> ScienceDaily. 17 December 2015</span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFGnantMlineritschSchippinger2009" class="citation journal cs1">Gnant, M; Mlineritsch, B; Schippinger, W;  et al. (February 2009). "Endocrine therapy plus zoledronic acid in premenopausal breast cancer". <i>N. Engl. J. Med</i>. <b>360</b> (7): 679–91. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa0806285  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa0806285'" tppabs="https://doi.org/10.1056%2FNEJMoa0806285" class="external text external">10.1056/NEJMoa0806285</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19213681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19213681'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19213681" class="external text external">19213681</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFColemanWinterCameron2010" class="citation journal cs1">Coleman RE, Winter MC, Cameron D,  et al. (March 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093" class="external text external">"The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer"</a>. <i>Br. J. Cancer</i>. <b>102</b> (7): 1099–105. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bjc.6605604  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bjc.6605604'" tppabs="https://doi.org/10.1038%2Fsj.bjc.6605604" class="external text external">10.1038/sj.bjc.6605604</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853093" class="external text external">2853093</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20234364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20234364'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20234364" class="external text external">20234364</a>.</cite></span></li><li id="cite_note-pmid18515735-28"> <span id="mw-reference-text-cite_note-pmid18515735-28" class="mw-reference-text"><cite id="CITEREFBrufskyBundredColeman2008" class="citation journal cs1">Brufsky A, Bundred N, Coleman R,  et al. (May 2008). "Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole". <i>Oncologist</i>. <b>13</b> (5): 503–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1634%2Ftheoncologist.2007-0206  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1634%2Ftheoncologist.2007-0206'" tppabs="https://doi.org/10.1634%2Ftheoncologist.2007-0206" class="external text external">10.1634/theoncologist.2007-0206</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18515735  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18515735'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18515735" class="external text external">18515735</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFTonyaliArslanAltundag2010" class="citation journal cs1">Tonyali O, Arslan C, Altundag K (November 2010). "The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives". <i>Expert Opin Pharmacother</i>. <b>11</b> (16): 2715–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2010.523699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2010.523699'" tppabs="https://doi.org/10.1517%2F14656566.2010.523699" class="external text external">10.1517/14656566.2010.523699</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20977404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20977404'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20977404" class="external text external">20977404</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:26073229  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:26073229'" tppabs="https://api.semanticscholar.org/CorpusID:26073229" class="external text external">26073229</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFDeleaTanejaSofryginKaura2010" class="citation journal cs1">Delea TE, Taneja C, Sofrygin O, Kaura S, Gnant M (August 2010). "Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer". <i>Clin. Breast Cancer</i>. <b>10</b> (4): 267–74. doi:<a href="javascript:if(confirm('https://doi.org/10.3816%2FCBC.2010.n.034  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3816%2FCBC.2010.n.034'" tppabs="https://doi.org/10.3816%2FCBC.2010.n.034" class="external text external">10.3816/CBC.2010.n.034</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20705558  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20705558'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20705558" class="external text external">20705558</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    

<div role="navigation" class="navbox" aria-labelledby="Drugs_for_treatment_of_bone_diseases_(M05)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_for_treatment_of_bone_diseases_(M05)" style="font-size:114%;margin:0 4em">Drugs for treatment of bone diseases (M05)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Bisphosphonates</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">Nitrogenous</a> (<a href="Alendronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Alendronic_acid" title="Alendronic acid">Alendronic acid</a></li>
<li><a href="Ibandronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibandronic_acid" title="Ibandronic acid">ibandronic acid</a></li>
<li>incadronic acid</li>
<li><a href="Pamidronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Pamidronic_acid" title="Pamidronic acid">pamidronic acid</a></li>
<li><a href="Risedronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Risedronic_acid" title="Risedronic acid">risedronic acid</a></li>
<li><a href="Zoledronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Zoledronic_acid" title="Zoledronic acid">zoledronic acid</a>)<br>Non-nitrogenous (<a href="Etidronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Etidronic_acid" title="Etidronic acid">Etidronic acid</a></li>
<li><a href="Clodronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Clodronic_acid" title="Clodronic acid">clodronic acid</a></li>
<li><a href="Tiludronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiludronic_acid" title="Tiludronic acid">tiludronic acid</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Bone morphogenetic proteins</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dibotermin alfa</li>
<li>Eptotermin alfa</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Resorption inhibitor</i> (<a href="Ipriflavone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ipriflavone" title="Ipriflavone">Ipriflavone</a>)</li>
<li><a href="Aluminium_chlorohydrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Aluminium_chlorohydrate" title="Aluminium chlorohydrate">Aluminium chlorohydrate</a></li>
<li><i>Dual action bone agent</i> (Strontium ranelate)</li>
<li><br> <i>RANKL inhibitor</i> (Denosumab)</li>
<li><i>Sclerostin inhibitor</i> (Romosozumab)</li>
<li><i>Cathepsin K inhibitor</i> (Odanacatib)</li>
<li><a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">Calcium</a></li>
<li><a href="Vitamin_D.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_D" title="Vitamin D">Vitamin D</a></li></ul>
</div></td></tr></tbody></table></div>



<meta property="mw:PageProp/categorydefaultsort" content="Zoledronic Acid">






<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-30" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Zoledronic_acid&oldid=970226487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Zoledronic_acid&oldid=970226487'" tppabs="https://en.wikipedia.org/wiki/?title=Zoledronic_acid&oldid=970226487">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>